2 February 2023 in Nature Communications
Flavin containing monooxygenases (FMOs) are promiscuous enzymes known for metabolizing a wide range of exogenous compounds. In C. elegans, fmo-2 expression increases lifespan and healthspan downstream of multiple longevity-promoting pathways through an unknown mechanism. Here, we report that, beyond its classification as a xenobiotic enzyme, fmo-2 expression leads to rewiring of endogenous metabolism principally through changes in one carbon metabolism (OCM). These changes are likely relevant, as we find that genetically modifying OCM enzyme expression leads to alterations in longevity that interact with fmo-2 expression. Using computer modeling, we identify decreased methylation as the major OCM flux modified by FMO-2 that is sufficient to recapitulate its longevity benefits. We further find that tryptophan is decreased in multiple mammalian FMO overexpression models and is a validated substrate for FMO-2. Our resulting model connects a single enzyme to two previously unconnected key metabolic pathways and provides a framework for the metabolic interconnectivity of longevity-promoting pathways such as dietary restriction. FMOs are well-conserved enzymes that are also induced by lifespan-extending interventions in mice, supporting a conserved and important role in promoting health and longevity through metabolic remodeling.
1 January 2025 in Women's Health
Background: Breast self-examination (BSE) was previously recommended to help early-stage breast cancer detection to improve prognosis. However, BSE is not recommended in the United States anymore due to the findings that it fails to significantly decrease mortality while increasing biopsy cases, causing unnecessary harm. Nonetheless, international researchers have continued to investigate the benefits of BSE in medically underserved regions. These studies raise the possibility that BSE could be beneficial in rural America, where people face higher mortality from chronic diseases compared to the general population. Objectives: Determine if BSE has benefits for medically underserved populations to inform a potential reevaluation of breast cancer screening recommendations. Design: Systematic review. Data Sources and Methods: A systematic review was conducted using a set of terms to identify articles on breast cancer survival and BSE in rural and/or underserved populations within the past 10 years. The search yielded over 200 articles across 3 databases (PubMed, CINAHL, and SCOPUS), and they were further screened to include studies that show rural populations performing BSE, effects of BSE in breast cancer diagnosis and/or mortality of breast cancer patients, factors contributing to the efficacy of BSE, factors that affect women’s willingness to perform BSE, and effects of BSE on breast cancer awareness/behaviors to seek further screening. Results: The final synthesis from 12 articles suggests that BSE is associated with early breast cancer detection (4/12), increased accessibility to breast cancer screening (2/12), and positively influence women to seek further breast cancer screening in rural populations (3/12). It also identifies a potential need for improved education on breast cancer and screening, including BSE practices, to promote early breast cancer detection (3/12). Conclusion: The reevaluation of the current recommendations to determine if exceptions should be made to specific populations would be helpful in addressing late detection and poor prognosis in medically underserved populations.